New tool twice as accurate at predicting antibody resistance among US children with Kawasaki disease
A new tool could one day help clinicians better predict resistance to immunoglobulin therapy among children with Kawasaki disease in the United States. Compared to the Kobayashi score -- the most widely used method in Japan for predicting resistance to the antibody, intravenous immunoglobulin (IVIG), in Kawasaki disease -- the newly developed tool is twice as accurate for Western New York children, achieving a sensitivity (detection) rate of 54%.